قضية هايبرتريجليسيريديميا والأعراض

Recent Hypertriglyceridemia News

• FDA approves Mylan's ANDA for Fenofibrate TabletsMylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg.
• GLP-1 pancreatitis concerns justifiedStudy results have raised further concerns over a link between pancreatitis and the use of glucagon-like peptide-1 (GLP-1)-based therapies for patients with Type 2 diabetes.
• Metabolic syndrome risk factors prevalent in bipolar disorderPeople who have bipolar disorder are at a high risk for developing the metabolic syndrome and related cardiovascular disorders, say researchers.
• Scientists demonstrate importance of Plvap gene in mammalian physiologyDartmouth scientists have demonstrated the importance of the gene Plvap and the structures it forms in mammalian physiology in a study published in December by the journal Developmental Cell.
• Janssen receives FDA approval for ZYTIGA to treat metastatic castration-resistant prostate cancerJanssen announced today that the U.S. Food and Drug Administration (FDA) has approved a broader indication for the oral, once-daily medication ZYTIGA (abiraterone acetate).